The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This issue brief provides an overview of the Medicare Part D prescription drug benefit plan landscape for 2020, with a focus on stand-alone drug plans, the largest segment of the Part D market. It includes national and state-level data on plan availability, premiums, benefit design, cost sharing, information about premium-free plans for low-income beneficiaries, and information about the national Part D plans available in 2020.
This fact sheet explains 2020 health coverage options that may be available to people who have low incomes, including Medicaid coverage or individual insurance plans through Affordable Care Act (ACA) marketplaces.
This summary examines key findings from the Kaiser Family Foundation and California Health Care Foundation California Health Policy Survey among low-income Californians. This brief examines the attitudes and experiences of low-income Californians with health care costs, access, and mental health services.
The Medicare Part D program provides an outpatient prescription drug benefit to older adults and people with long-term disabilities in Medicare who enroll in private plans. This analysis provides the latest data about Medicare Part D coverage and costs in 2019 and trends over time, including enrollment, premiums, cost sharing, and participation in the low-income subsidy program.
As policymakers debate how to address the high cost of prescription drugs, a new KFF analysis compares data on prescription drug spending and use across large employer plans, Medicare Part D and Medicaid, and provides context for policy discussions about different approaches to curb rising drug costs that would affect people covered by each of…
Prescription drug costs are a pressing concern for both consumers and policymakers. This analysis compares prescription drug spending and use in large private employer plans, Medicare Part D, and Medicaid, based primarily on claims data by payer, which does not account for rebates.
The latest Chart of the Week provides a look at the socioeconomic breakdown of the uninsured population in California, sourced from KFF's State Health Facts database.
The number of uninsured people rose by nearly 700,000, to 27.4 million people, in 2017, reversing some of the coverage gains achieved under the Affordable Care Act, according to latest analysis of uninsured data by KFF (the Kaiser Family Foundation).
A new Kaiser Family Foundation brief and interactive map provide the latest national and state-level estimates from the U.S. Census Bureau of the share and number of people ages 65 and older who are living in poverty.
This issue brief provides an overview of the Medicare Part D prescription drug benefit plan landscape, with a focus on stand-alone drug plans, the largest segment of the Part D market. It includes national and state-level data on plan availability, premiums, benefit design, cost sharing, information about premium-free plans for low-income beneficiaries, and information about the top ten Part D plans for 2019.
© 2025 KFF